Canada markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
40.10+0.60 (+1.52%)
At close: 04:00PM EDT
40.10 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
9,434
18,437
32,166
Cost of Revenue
0
-
-
-
-
Gross Profit
3,500
-
-
-
-
Operating Expenses
Research Development
167,512
167,512
105,767
75,463
50,523
Selling General and Administrative
46,542
46,542
32,810
21,967
12,944
Total Operating Expenses
214,054
214,054
138,577
97,430
63,467
Operating Income or Loss
-214,054
-214,054
-129,143
-78,993
-31,301
Interest Expense
-
-
0
0
484
Total Other Income/Expenses Net
3,749
3,749
-4,825
-361
412
Income Before Tax
-182,685
-182,685
-125,255
-78,888
-29,094
Income Tax Expense
-292
-292
118
-6
-257
Income from Continuing Operations
-182,393
-182,393
-125,373
-78,882
-28,837
Net Income
-182,393
-182,393
-125,373
-78,882
-28,837
Net Income available to common shareholders
-182,393
-182,393
-124,936
-77,087
-28,013
Basic EPS
-2.66
-
-2.06
-1.77
-0.81
Diluted EPS
-2.66
-
-2.06
-1.77
-0.81
Basic Average Shares
65,811
-
60,542
43,627
34,542
Diluted Average Shares
65,811
-
60,542
43,627
34,542